← Back to headlines
TD Cowen Raises Abbott Labs Price Target on Cancer Diagnostics Growth
TD Cowen has increased its stock price target for Abbott Laboratories, citing strong growth in the company's cancer diagnostics segment as the primary driver for the upgrade.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
